Topoisomerase III-ß is required for efficient replication of positive-sense RNA viruses.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
27 Mar 2020
Historique:
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 9 6 2020
Statut: epublish

Résumé

Based on genome-scale loss-of-function screens we discovered that Topoisomerase III-ß (TOP3B), a human topoisomerase that acts on DNA and RNA, is required for yellow fever virus and dengue virus-2 replication. Remarkably, we found that TOP3B is required for efficient replication of all positive-sense-single stranded RNA viruses tested, including SARS-CoV-2. While there are no drugs that specifically inhibit this topoisomerase, we posit that TOP3B is an attractive anti-viral target.

Identifiants

pubmed: 32511318
doi: 10.1101/2020.03.24.005900
pmc: PMC7239047
pii:
doi:

Types de publication

Preprint

Langues

eng

Commentaires et corrections

Type : UpdateIn

Déclaration de conflit d'intérêts

Conflict of interest statement. MTB is a cofounder of EpiCypher. Others declare no competing interests.

Références

Nat Med. 2017 Jun;23(6):763-767
pubmed: 28394328
Nucleic Acids Res. 2016 Jul 27;44(13):6335-49
pubmed: 27257063
J Pharm Pharmacol. 2013 Feb;65(2):157-70
pubmed: 23278683
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5717-21
pubmed: 11331780
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5544-51
pubmed: 27582462
mBio. 2019 May 14;10(3):
pubmed: 31088929
Nat Neurosci. 2013 Sep;16(9):1228-1237
pubmed: 23912948
Cell Host Microbe. 2016 Aug 10;20(2):259-70
pubmed: 27476412
Nat Neurosci. 2013 Sep;16(9):1238-47
pubmed: 23912945
Science. 2016 May 27;352(6289):aad7993
pubmed: 27127234
Treat Respir Med. 2006;5(6):437-65
pubmed: 17154673
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
J Biol Chem. 2005 Aug 5;280(31):28476-83
pubmed: 15955813
Front Microbiol. 2019 Sep 13;10:2145
pubmed: 31572348
Virology. 2005 Feb 5;332(1):20-7
pubmed: 15661137
Nature. 2009 Apr 23;458(7241):1047-50
pubmed: 19396146
Sci Rep. 2019 Jul 4;9(1):9711
pubmed: 31273220
Mol Cell. 2014 Feb 6;53(3):484-97
pubmed: 24507716
PLoS Negl Trop Dis. 2012;6(9):e1820
pubmed: 23029581
Nat Rev Mol Cell Biol. 2016 Nov;17(11):703-721
pubmed: 27649880

Auteurs

K Reddisiva Prasanth (KR)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.

Minato Hirano (M)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.

W Samuel Fagg (WS)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
Transplant Division, Department of Surgery, University of Texas Medical Branch, Galveston, Texas, USA.

Eileen T McAnarney (ET)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.

Chao Shan (C)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.

Xuping Xie (X)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.

Adam Hage (A)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.

Colette A Pietzsch (CA)

Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, USA.

Alexander Bukreyev (A)

Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, USA.

Ricardo Rajsbaum (R)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Institute of Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA.

Pei-Yong Shi (PY)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
Institute of Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA.

Mark T Bedford (MT)

Department of Epigenetics and Molecular Carcinogenesis, MD Anderson Cancer Center, Smithville, Texas, USA.

Shelton S Bradrick (SS)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
Institute of Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA.

Vineet Menachery (V)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.

Mariano A Garcia-Blanco (MA)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
Institute of Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA.
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.

Classifications MeSH